Vaccine News and Research

Latest Vaccine News and Research

New study shows link between blood type and severity of diarrhea caused by E. coli

A new study shows that a kind of E. coli most associated with "travelers' diarrhea" and children in underdeveloped areas of the world causes more severe disease in people with blood type A.

18 May 2018

Experts available to discuss subjects related to Ebola virus

Georgetown University Medical Center (GUMC) professors offer expertise for journalists seeking interviews in a variety of subjects related to Ebola.

18 May 2018

Ebola outbreak spreads to Congo city of 1 million

There has been a confirmed case of Ebola in the Mbandaka city of Congo that has a population of 1.2 million. This is the first urban case in the latest outbreak and is being considered to be one of the most serious ones in recent times. The last major outbreaks have affected people across West Africa between 2014 and 2016.

18 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Prenatal test to determine child's rhesus factor found to be reliable, but benefit is unclear

If the blood of a pregnant woman is rhesus-negative and the blood of the fetus is rhesus-positive, the woman may develop antibodies, which can cause severe harm to subsequent children in particular.

16 May 2018

Computer models provide valuable insight to structure and function of Ebola, Zika viruses

The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host's cells. Through the computer modeling capabilities of Los Alamos National Laboratory, the molecular calisthenics involved in invading a cell are visually documented, an essential step toward vaccine and therapeutic medicine development.

15 May 2018

Study: Antibodies against hemorrhagic fever disarm two viruses of same family

Hemorrhagic fever viruses, so named for their ability to induce massive, and at times fatal, internal bleeding, captured the world's attention during the Ebola outbreak of 2014-2016 in West Africa.

15 May 2018

Disease tolerance is the key to treating TB, say experts

A new study from McGill University suggests it is the body’s ability to “tolerate” rather than “resist” TB infection that stops symptoms of the disease developing.

14 May 2018

ICON and DuPage Medical Group announce clinical research partnership

ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.

14 May 2018

HPV vaccine for girls gets thumbs up from Cochrane review

According to a Cochrane review that was released recently, the HPV vaccine, that can protect girls and young women from Human Papilloma virus (HPV) can help protect them against cancer of the cervix later in life. The report appears in the latest issue of the Cochrane Database of Systematic Reviews.

13 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements.

10 May 2018

Poison ivy and poison oak can cause mild to severe allergic reactions

April showers might bring May flowers, but they also bring the arrival of troublesome plants such as poison ivy and poison oak that can cause mild to severe allergic reactions.

9 May 2018

Mass vaccinations are not realistic option to prevent Ebolavirus outbreaks, study shows

Prophylactic mass vaccination programs are not a realistic option in the battle to prevent new Ebolavirus outbreaks, a University of Kent-led research team has shown.

9 May 2018

Newly developed technique allows researchers to study liver stage malaria

A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver.

9 May 2018

Human papilloma virus vaccines can protect against cervical lesions in young women

New evidence published today in the Cochrane Library shows that human papilloma virus vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26.

9 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

Vaccine News and Research

Latest Vaccine News and Research

New study shows link between blood type and severity of diarrhea caused by E. coli

Experts available to discuss subjects related to Ebola virus

Ebola outbreak spreads to Congo city of 1 million

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Prenatal test to determine child's rhesus factor found to be reliable, but benefit is unclear

Computer models provide valuable insight to structure and function of Ebola, Zika viruses

Study: Antibodies against hemorrhagic fever disarm two viruses of same family

Disease tolerance is the key to treating TB, say experts

ICON and DuPage Medical Group announce clinical research partnership

HPV vaccine for girls gets thumbs up from Cochrane review

Addressing Antimicrobial Resistance Through Industry

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

Poison ivy and poison oak can cause mild to severe allergic reactions

Mass vaccinations are not realistic option to prevent Ebolavirus outbreaks, study shows

Newly developed technique allows researchers to study liver stage malaria

Human papilloma virus vaccines can protect against cervical lesions in young women

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Phase 2 clinical study of universal influenza vaccine begins in the United States

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in